Evolent Health (EVH) Tops Q1 EPS by 5c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Evolent Health Announces First Quarter 2021 Results
May 5, 2021 4:02 PM EDTWASHINGTON, May 5, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2021.
Highlights from the first quarter of 2021 announcement include:
Quarter ended March 31, 2021:
GAAP revenue of $215.1 million. Net loss attributable to common shareholders of Evolent Health, Inc. of $(9.8) million. Achieved Adjusted EBITDA of $14.9 million. Lives on Full Platform of approximately 3.4 million and New Century Health Technology & Services Suite of 8.2Â million, for a... More